Paul L Berns - Net Worth and Insider Trading
Paul L Berns Net Worth
The estimated net worth of Paul L Berns is at least $3 Million dollars as of 2024-06-08. Paul L Berns is the President and CEO of Anacor Pharmaceuticals Inc and owns about 230,311 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $2 Million. Paul L Berns is the Director of Jazz Pharmaceuticals PLC and owns about 8,290 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $928,895. Paul L Berns is also the Director of Cellectar Biosciences Inc and owns about 1,174 shares of Cellectar Biosciences Inc (CLRB) stock worth over $3,909. Details can be seen in Paul L Berns's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul L Berns has not made any transactions after 2021-08-05 and currently still holds the listed stock(s).
Transaction Summary of Paul L Berns
Paul L Berns Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul L Berns owns 8 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) , Unity Biotechnology Inc (UBX) , and VYNE Therapeutics Inc (VYNE) among others .
Click here to see the complete history of Paul L Berns’s form 4 insider trades.
Insider Ownership Summary of Paul L Berns
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
JAZZ | Jazz Pharmaceuticals PLC | 2021-08-05 | director |
UBX | Unity Biotechnology Inc | 2020-06-18 | director |
VYNE | VYNE Therapeutics Inc | 2019-06-25 | director |
2016-06-24 | director & President and CEO | ||
2016-05-17 | director | ||
2016-04-20 | director | ||
2021-12-17 | director | ||
2023-09-14 | director |
Paul L Berns Latest Holdings Summary
Paul L Berns currently owns a total of 3 stocks. Among these stocks, Paul L Berns owns 230,311 shares of Anacor Pharmaceuticals Inc (ANAC) as of March 22, 2016, with a value of $2 Million and a weighting of 70.8%. Paul L Berns owns 8,290 shares of Jazz Pharmaceuticals PLC (JAZZ) as of August 5, 2021, with a value of $928,895 and a weighting of 29.08%. Paul L Berns also owns 1,174 shares of Cellectar Biosciences Inc (CLRB) as of April 20, 2016, with a value of $3,909 and a weighting of 0.12%.
Latest Holdings of Paul L Berns
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ANAC | Anacor Pharmaceuticals Inc | 2016-03-22 | 230,311 | 9.82 | 2,261,654 |
JAZZ | Jazz Pharmaceuticals PLC | 2021-08-05 | 8,290 | 112.05 | 928,895 |
CLRB | Cellectar Biosciences Inc | 2016-04-20 | 1,174 | 3.33 | 3,909 |
Holding Weightings of Paul L Berns
Paul L Berns Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul L Berns has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 37,500 shares on March 22, 2016, which brought Paul L Berns around $2 Million.
According to the SEC Form 4 filings, Paul L Berns has made a total of 4 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 1,450 shares on August 5, 2021, which brought Paul L Berns around $223,300.
According to the SEC Form 4 filings, Paul L Berns has made a total of 0 transactions in Cellectar Biosciences Inc (CLRB) over the past 5 years. The most-recent trade in Cellectar Biosciences Inc is the acquisition of 1,174 shares on April 20, 2016, which cost Paul L Berns around $248,826.
Insider Trading History of Paul L Berns
- 1
Paul L Berns Trading Performance
GuruFocus tracks the stock performance after each of Paul L Berns's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul L Berns is 25.37%. GuruFocus also compares Paul L Berns's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul L Berns within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul L Berns's insider trading performs compared to the benchmark.
Performance of Paul L Berns
Paul L Berns Ownership Network
Ownership Network List of Paul L Berns
Ownership Network Relation of Paul L Berns
Paul L Berns Owned Company Details
What does Jazz Pharmaceuticals PLC do?
Who are the key executives at Jazz Pharmaceuticals PLC?
Paul L Berns is the director of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include SVP & General Counsel Neena M Patil , VP & Finance& PAO Patricia Carr , and director & 10 percent owner Patrick G Enright .
Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary
Over the past 18 months, Paul L Berns made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 6,301 shares made by Patricia Carr , a net sale of 8,850 shares made by Neena M Patil , and a net sale of 1,593 shares made by Samantha Pearce .
In summary, during the past 3 months, insiders sold 5,000 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 5,000 shares. During the past 18 months, 54,054 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 42,054 shares.
Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jazz Pharmaceuticals PLC Insider Transactions
Paul L Berns Mailing Address
Above is the net worth, insider trading, and ownership report for Paul L Berns. You might contact Paul L Berns via mailing address: 11080 Circlepoint Rd., Ste, 200, Westminster Co 80020.